PainReform Ltd. Files Q2 2024 Financial Results
Ticker: PRFX · Form: 6-K · Filed: Aug 15, 2024 · CIK: 1801834
| Field | Detail |
|---|---|
| Company | Painreform Ltd. (PRFX) |
| Form Type | 6-K |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 6-K, foreign-private-issuer
TL;DR
PainReform dropped its Q2 2024 financials on 8/15 - check the filings for details.
AI Summary
On August 15, 2024, PainReform Ltd. announced its financial results for the second quarter ended June 30, 2024. The company is a foreign private issuer based in Israel and is incorporated under the laws of Israel. This Form 6-K filing is incorporated by reference into several of the Company's existing registration statements.
Why It Matters
This filing provides investors with the latest financial performance data for PainReform Ltd., crucial for assessing the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) that does not introduce new material risks or significant changes.
Key Numbers
- Q2 2024 — Reporting Period (Financial results for the second quarter ended June 30, 2024.)
Key Players & Entities
- PainReform Ltd. (company) — Registrant
- August 15, 2024 (date) — Date of press release and filing
- June 30, 2024 (date) — End of reporting period (Q2)
- Israel (location) — Country of incorporation and principal executive offices
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to announce PainReform Ltd.'s financial results for the second quarter ended June 30, 2024, via a press release issued on August 15, 2024.
When did PainReform Ltd. file this Form 6-K?
The filing date for this Form 6-K is August 15, 2024.
What period do the financial results in this filing cover?
The financial results cover the second quarter ended June 30, 2024.
Where are PainReform Ltd.'s principal executive offices located?
PainReform Ltd.'s principal executive offices are located at 65 Yigal Alon St., Tel Aviv, Israel.
Into which existing registration statements is this Form 6-K incorporated by reference?
This Form 6-K is incorporated by reference into the Company's Registration Statements on Form S-8 (Registration No. 333-257a968 and 333-265902) and Form F-3 (Registration No. 333-259318, 333-254982 and 333-276485).
Filing Stats: 306 words · 1 min read · ~1 pages · Grade level 8.8 · Accepted 2024-08-15 16:45:16
Filing Documents
- zk2431831.htm (6-K) — 19KB
- exhibit_99-1.htm (EX-99.1) — 569KB
- exhibit_99-2.htm (EX-99.2) — 89KB
- exhibit_99-3.htm (EX-99.3) — 14KB
- image00001.jpg (GRAPHIC) — 336KB
- 0001178913-24-002662.txt ( ) — 3864KB
- prfx-20240630.xsd (EX-101.SCH) — 47KB
- prfx-20240630_cal.xml (EX-101.CAL) — 26KB
- prfx-20240630_def.xml (EX-101.DEF) — 94KB
- prfx-20240630_lab.xml (EX-101.LAB) — 513KB
- prfx-20240630_pre.xml (EX-101.PRE) — 165KB
- zk2431831_htm.xml (XML) — 385KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: August 15, 2024 PAINREFORM LTD. By: /s/ Ehud Geller Ehud Geller Interim Chief Executive Officer